1
|
Stroeks SLVM, Verdonschot JAJ, Lunde IG, Henkens MTHM, Willemars M, Schianchi F, Luiken JFP, Wang P, Derks K, Krapels IPC, Vanhoutte EK, Jones EAV, Brunner HG, Nabben M, Heymans SRB. Titin truncating variant cardiomyopathy and related sarcomere insufficiency causes high energy demand resulting in mitochondrial dysfunction, autophagosome formation, and apoptosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background/Objectives
Titin truncating variants (TTNtv) are the most prevalent genetic cause of dilated cardiomyopathy (DCM), resulting in upregulation of cardiac transcripts of oxidative phosphorylation (1,2). However, the underlying molecular mechanism(s) and cellular consequences of these findings remain unknown.
Methods and results
To gain insight into the metabolic changes and cellular consequences of a TTNtv, metabolic, mitochondrial, and survival pathways were studied in human TTNtv DCM hearts and isolated cardiomyocytes of TTNtv mice. TTNtv resulted in a significant increase of cardiac transcripts of glycolysis, citric acid cycle, mitochondrial fission, autophagy, and apoptosis when comparing RNAseq in 24 TTNtv and 27 mutation-negative DCM cardiac biopsies. Furthermore, a decrease in the area of myofibrils in human TTNtv hearts (TTNtv vs. mutation-negative DCM: 46%, and 62%, P=0.001), and an increase of mitochondrial (49% and 31%, P=0,001) and autophagosome areas (4% and 2%, P=0.002) was observed using transmission electron microscopy (TEM). Similar patterns of cardiomyocyte disorganization and stress could be seen in TTNtv hearts of mice even without a phenotype. Additionally, observed swollen mitochondria by TEM and decreased quantity of OXPHOS proteins by immunoblotting in murine TTNtv hearts indicate mitochondrial stress. Mitochondrial oxygen consumption at baseline and the maximum respiration in TTNtv cardiomyocytes of mice increased by a factor of 1.8 and 1.5 respectively (both P≤0.05), compared to WT. Furthermore, palmitate oxidation in TTNtv cardiomyocytes increased by 1.3 fold (P=0.005) compared to WT mice, suggestive of increased energy demand in TTNtv.
Conclusion
Myofibrillar insufficiency in human TTNtv DCM augments the cardiac oxygen and energy consumption, leading to pronounced morphological and functional mitochondrial decompensation. Swelling, damage and fission of mitochondria is further characterized by autophagosome formation and increased apoptosis pathways in TTNtv hearts.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Double-Dose consortium by Dutch Cardiovascular Alliance (DCVA)
Collapse
Affiliation(s)
- S L V M Stroeks
- Cardiovascular Research Institute Maastricht (CARIM), Cardiology , Maastricht , The Netherlands
| | - J A J Verdonschot
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | - I G Lunde
- Harvard Medical School , Boston , United States of America
| | - M T H M Henkens
- Cardiovascular Research Institute Maastricht (CARIM) , Maastricht , The Netherlands
| | - M Willemars
- Cardiovascular Research Institute Maastricht (CARIM), Genetics and Cell Biology , Maastricht , The Netherlands
| | - F Schianchi
- Cardiovascular Research Institute Maastricht (CARIM), Genetics and Cell Biology , Maastricht , The Netherlands
| | - J F P Luiken
- Cardiovascular Research Institute Maastricht (CARIM), Genetics and Cell Biology , Maastricht , The Netherlands
| | - P Wang
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | - K Derks
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | - I P C Krapels
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | - E K Vanhoutte
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | | | - H G Brunner
- Academic Hospital Maastricht, Clinical Genetics , Maastricht , The Netherlands
| | - M Nabben
- Cardiovascular Research Institute Maastricht (CARIM), Genetics and Cell Biology , Maastricht , The Netherlands
| | - S R B Heymans
- Cardiovascular Research Institute Maastricht (CARIM), Cardiology , Maastricht , The Netherlands
| |
Collapse
|
2
|
Loid M, Obukhova D, Derks K, Meltsov A, Kask K, Altmäe S, Saare M, Peters M, Esteki MZ, Salumets A. P-322 Does endometrium age? The endometrial transcriptome of advanced reproductive age patients reveals the signs of cellular ageing, altered immune response and compromised receptivity. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
What changes occur in the endometrium during ageing and how they may affect fertility?
Summary answer
The endometrial transcriptome of women of advanced maternal age is significantly different from the young women, indicating specific pathways involved in endometrial ageing.
What is known already
A woman’s peak reproductive years are considered in her twenties. Trending postponed family planning, unfortunately, brings more women in their late forties to fertility specialists to seek for assisted conception. In vitro fertilization (IVF) using donated oocytes is a common approach to overcome the impact of maternal age on ovarian reserve. However, even with the implementation of embryo that underwent pre-implantation genetic testing, the IVF success rate drops significantly in the late forties. It still remains unclear which age-related molecular processes take place in the endometrium and whether it may impact the ability to support embryo implantation.
Study design, size, duration
Endometrial transcriptome profiling was done in 44 women undergoing endometrial receptivity evaluation at hormonal replacement therapy before IVF. Patients younger than 29 were considered as young maternal age group (YMA, age 23-27) and women older than 45 were considered as advanced maternal age group (AMA, age 47-50).
Participants/materials, setting, methods
Endometrial biopsies were obtained on day 5 of progesterone treatment and RNA was extracted. All endometrial samples were evaluated as receptive based on the expression of 57 common endometrial receptivity markers. Study group samples (12 YMA + 12 AMA) were subject to Illumina RNA sequencing. The sequences were annotated using the RefSeq database and differential expression analysis was performed using DeSeq2.We validated our results (10 YMA + 10 AMA) usingquantitative-PCR and histological validation.
Main results and the role of chance
A total of 37228 mRNA transcripts were expressed in the analyzed endometrial samples. After multiple testing corrections, 144 significantly differentially expressed(DE) transcripts (92 up-regulated, 52 down-regulated) were identified in the endometrium of the AMA versus YMAgroup. Overexpressed genes were associated with decidualization (ALDH3A1), endometrial receptivity (EML5, GALNT12), cell cycle (CDKN2A) and signal transduction, while down-regulated genes included sugar metabolism and inflammation (C2CD4B, NFKB), cellular motility (SPAG6)and progesterone signaling (RPL9). The pathways most affected by age were cellular remodeling, cell motility and migration, and immune response. Interestingly, some of the identified DE genes have been previously associated with ageing. Our results suggest the involvement of p16-associated cellular senescence and the suppression of metabolic and inflammatory processes essential for endometrial preparation for embryo transfer.
Limitations, reasons for caution
The study includes only patients undergoing hormonal replacement therapy and it is unclear whether the same processes are affected by age in the natural cycles.
Wider implications of the findings
These findings allow us to explain the age-related molecular changes that take place in the endometrial tissue. Understanding these alterations and using them in assisted reproductive technology may help to improve infertility management in women with advanced reproductive age.
Trial registration number
None
Collapse
Affiliation(s)
- M Loid
- University of Tartu, Department of Obstetrics and Gynecology- Institute of Clinical Medicine , Tartu, Estonia
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
| | - D Obukhova
- Maastricht University Medical Center+, Department of Clinical Genetics , Maastricht, The Netherlands
| | - K Derks
- Maastricht University Medical Center+, Department of Clinical Genetics , Maastricht, The Netherlands
| | - A Meltsov
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
| | - K Kask
- University of Tartu, Department of Obstetrics and Gynecology- Institute of Clinical Medicine , Tartu, Estonia
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
| | - S Altmäe
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
- University of Granada, Department of Biochemistry and Molecular Biology , Granada, Spain
| | - M Saare
- University of Tartu, Department of Obstetrics and Gynecology- Institute of Clinical Medicine , Tartu, Estonia
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
| | - M Peters
- University of Tartu, Department of Obstetrics and Gynecology- Institute of Clinical Medicine , Tartu, Estonia
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
| | - M Z Esteki
- Maastricht University Medical Center+, Department of Clinical Genetics , Maastricht, The Netherlands
| | - A Salumets
- University of Tartu, Department of Obstetrics and Gynecology- Institute of Clinical Medicine , Tartu, Estonia
- Competence Centre on Health Technologies, Competence Centre on Health Technologies , Tartu, Estonia
- University of Tartu, Estonian Genome Center- Institute of Genomics , Tartu, Estonia
- Division of Obstetrics and Gynecology- Department of Clinical Science- Intervention and Technology CLINTEC, Karolinska Institutet , Stockholm, Sweden
| |
Collapse
|
3
|
Liapi E, Verhesen W, Derks K, Van Leeuwen REW, Schroen B. 397tRNA fragments are novel obesity-regulated components of the small cardiac RNAome. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy060.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- E Liapi
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Maastricht, Netherlands
| | - W Verhesen
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Maastricht, Netherlands
| | - K Derks
- Maastricht University Medical Centre (MUMC), Department of Clinical Genetics , Maastricht, Netherlands
| | - REW Van Leeuwen
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Maastricht, Netherlands
| | - B Schroen
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Maastricht, Netherlands
| |
Collapse
|
4
|
Kilic E, Smit K, van Poppelen N, Lunavat T, Derks K, Vaarwater J, Verdijk R, Mensink H, Lötvall J, de Klein A. miRNA profiling of uveal melanoma exosomes as a metastatic risk biomarker. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.03642] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- E. Kilic
- Ophthalmology; Erasmus MC; Rotterdam The Netherlands
| | - K. Smit
- Ophthalmology; Erasmus MC; Rotterdam The Netherlands
- Erasmus MC, Clinical Genetics; Rotterdam The Netherlands
| | - N. van Poppelen
- Ophthalmology; Erasmus MC; Rotterdam The Netherlands
- Erasmus MC, Clinical Genetics; Rotterdam The Netherlands
| | - T. Lunavat
- Internal Medicine; University of Gothenborg; Gothenborg Sweden
| | - K. Derks
- Maastricht UMC, Clinical Genetics; Maastricht The Netherlands
| | - J. Vaarwater
- Ophthalmology; Erasmus MC; Rotterdam The Netherlands
| | - R. Verdijk
- Pathology; Erasmus MC; Rotterdam The Netherlands
| | - H. Mensink
- Ophthalmology; Rotterdam Eye Hospital; Rotterdam The Netherlands
| | - J. Lötvall
- Internal Medicine; University of Gothenborg; Gothenborg Sweden
| | - A. de Klein
- Erasmus MC, Clinical Genetics; Rotterdam The Netherlands
| |
Collapse
|